Article Text

Download PDFPDF
Increased levels of uric acid predict haemodynamic compromise in patients with heart failure independently of B-type natriuretic peptide levels

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests: JMH is a paid consultant at Cardiome Pharma Corporation, a manufacturer of oxypurinol. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict of interest policies. Cardiome Pharma Corporation had no involvement in the study design, data collection or analysis, writing of the report, or in the decision to submit the paper for publication.